Petroleo Brasileiro SA Petrobras
PBR
Ecopetrol
EC
Vale SA
VALE
Meritage Homes
MTH
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
ALPMY Astellas Pharma (ADR)
- 9.665
- -0.015-0.15%
15min DelayTrading Jan 7 10:39 ET
17.30BMarket Cap50.08P/E (TTM)
9.800High9.664Low6.86KVolume9.800Open9.680Pre Close66.44KTurnover0.00%Turnover Ratio161.08P/E (Static)1.79BShares13.14052wk High1.78P/B17.30BFloat Cap9.15052wk Low0.48Dividend TTM1.79BShs Float18.789Historical High4.98%Div YieldTTM1.41%Amplitude0.508Historical Low9.680Avg Price1Lot Size
About Astellas Pharma (ADR) Company
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. The firm's global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
Company Profile
SymbolALPMY
Company NameAstellas Pharma (ADR)
Founded1923
CEOMr. Naoki Okamura
MarketPink Market
Employees16243
Fiscal Year Ends03-31
Address2-5-1 Nihonbashi-Honcho,Chuo-Ku
CityTokyo
ProvinceTokyo
CountryJapan
Zip Code103-8411
Phone81-3-3244-3000
Websitehttps://www.astellas.com/jp/
Company Executives
- Name
- Position
- Salary
- Naoki Okamura
- Director, President and Chief Executive Officer
- --
- Katsuyoshi Sugita
- Director, Executive Vice President, Chief People Officer, Chief Ethics and Compliance Officer
- --
- Kenji Yasukawa
- Chairman of the Board
- --
- Rika Hirota
- Director
- --
- Masahiro Miyazaki
- Independent Director
- --
- Eriko Sakurai
- Independent Director
- --
- Yoichi Ohno
- Independent Director
- --
- Takashi Tanaka
- Independent Director
- --
- Tomoko Aramaki
- Independent Director
- --
- Mika Nakayama
- Independent Director
- --
- Rie Akiyama
- Independent Director
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.